The exclusive interview for SPINOFF.COM with Shay Herchcovici, Head of Business Development at Betalin Therapeutics Ltd. on their technology of micro pancreas to fight diabetes.
Betalin Therapeutics is a biotech company developing the Engineered Micro Pancreas (EMP) to treat diabetes. This breakthrough technology will allow for the implantation of pancreatic, insulin-producing cells to restore the body's intrinsic insulin generation capabilities. The procedure involves injecting millions of islets (the pancreatic cell clusters that “house” the insulin-producing beta cells) harvested from cadavers, followed by immunosuppression therapy. The engineered bio-pancreas can be implanted virtually anywhere in the body. With such technology, the diabetes sufferers around the globe will be able to set themselves free of daily treatments.